Lidocaine, also known as xylocaine and lignocaine, is a medication used to numb tissue in a specific area and to treat ventricular tachycardia.[3][4] It can also be used for nerve blocks. Lidocaine mixed with a small amount of epinephrine is available to allow larger doses to be used as numbing and to make it last longer.[4] When used as an injectable it typically begins working within four minutes and lasts for half an hour to three hours.[4][5] Lidocaine may also be applied directly to the skin for numbing.[4]
Starting at
2-(diethylamino)-
N-(2,6-dimethylphenyl)acetamide |
Pronunciation |
Lidocaine /ˈlaɪdəˌkeɪn/[1][2] lignocaine /ˈlɪɡnəˌkeɪn/ |
Trade names | Xylocaine |
AHFS/Drugs.com |
Local monograph Injectable monograph |
Pregnancy category |
AU: A US: B (No risk in non-human studies) |
Legal status |
AU: S4 (Prescription only) US: ℞-only (OTC for ≤4%) |
Routes of administration |
intravenous, subcutaneous, topical, oral |
Bioavailability | 35% (oral) 3% (topical) |
Metabolism | Liver,[3] 90% CYP3A4-mediated |
Onset of action | within 1.5 min (IV)[3] |
Biological half-life | 1.5–2 h |
Duration of action | 10 to 20 min(IV),[3] 0.5 to 3 h (injection)[4][5] |
Excretion | Kidney[3] |
CAS Number | 137-58-6 73-78-9 (hydrochloride) |
ATC code | C01BB01 C05AD01 D04AB01 N01BB02 R02AD02 S01HA07 S02DA01 |
PubChem | CID: 367 |
IUPHAR/BPS | 2623 |
DrugBank | DB00281 |
ChemSpider | 3548 |
UNII | 98PI200987 |
KEGG | D00358 |
ChEBI | CHEBI:6456 |
ChEMBL | CHEMBL79 |
Synonyms | N-(2,6-dimethylphenyl)-N2,N2-diethylglycinamide |